Free Trial

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Receives Average Recommendation of "Buy" from Brokerages

EssilorLuxottica logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts give EssilorLuxottica Unsponsored ADR (OTCMKTS: ESLOY) an average recommendation of Buy from eight covering firms — five Buy, two Strong Buy and one Hold.
  • Several major brokerages have recently upgraded or reiterated positive ratings, including Goldman Sachs and Citigroup (Buy), Kepler and HSBC (upgraded to Buy), and UBS raising its view to Strong Buy.
  • Shares opened at $111.48 and are trading near the 52‑week low of $111.22 (versus a 52‑week high of $186.81), while the company shows low leverage with a debt‑to‑equity ratio of 0.17.
  • Five stocks we like better than EssilorLuxottica.

Shares of EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report) have earned an average recommendation of "Buy" from the eight research firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, five have given a buy rating and two have issued a strong buy rating on the company.

ESLOY has been the subject of a number of research reports. The Goldman Sachs Group reissued a "buy" rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Citigroup reiterated a "buy" rating on shares of EssilorLuxottica in a research note on Thursday, December 11th. Kepler Capital Markets raised EssilorLuxottica from a "hold" rating to a "buy" rating in a report on Thursday, January 15th. HSBC raised EssilorLuxottica from a "hold" rating to a "buy" rating in a research report on Wednesday, January 14th. Finally, UBS Group raised EssilorLuxottica from a "hold" rating to a "strong-buy" rating in a research report on Thursday, November 27th.

View Our Latest Analysis on EssilorLuxottica

EssilorLuxottica Stock Performance

OTCMKTS ESLOY opened at $111.48 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.70 and a current ratio of 0.99. EssilorLuxottica has a 52-week low of $111.22 and a 52-week high of $186.81. The company has a 50-day simple moving average of $142.22 and a 200 day simple moving average of $159.27.

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company's product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Featured Stories

Analyst Recommendations for EssilorLuxottica (OTCMKTS:ESLOY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EssilorLuxottica Right Now?

Before you consider EssilorLuxottica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EssilorLuxottica wasn't on the list.

While EssilorLuxottica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines